Tuesday, 25 September, 2018

Comparable Company Analysis: AbbVie Inc. (ABBV), Rockwell Collins Inc. (COL)

Nellie Chapman | 03 February, 2018, 01:11

Proshare Advisors Llc sold 86,463 shares as the company's stock rose 6.17% with the market. The institutional investor held 45,202 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $4.02M, up from 37,447 at the end of the previous reported quarter. Greatmark Investment Partners Inc. now owns 35,178 shares of the company's stock worth $2,551,000 after buying an additional 1,242 shares during the period. About 445,115 shares traded. It has underperformed by 7.92% the S&P500. Tuttle Tactical Management Llc who had been investing in Priceline Group Inc for a number of months, seems to be bullish on the $91.72B market cap company. The stock decreased 0.53% or $0.55 during the last trading session, reaching $103.22. The shares were sold at an average price of $94.69, for a total transaction of $2,427,188.77. It has outperformed by 46.10% the S&P500. Tompkins holds 31,383 shares or 0.66% of its portfolio. Therefore 56% are positive. Cowen & Co maintained AbbVie Inc. Finally, Jefferies Group reissued a "buy" rating and set a $107.00 target price on shares of AbbVie in a research note on Thursday, September 28th. The firm has "Market Perform" rating given on Thursday, November 16 by BMO Capital Markets. As per Friday, July 28, the company rating was maintained by Jefferies. Jefferies has "Buy" rating and $50.0 target. The firm earned "Outperform" rating on Friday, February 5 by William Blair. The firm has "Buy" rating given on Tuesday, December 5 by Leerink Swann.

Investors sentiment decreased to 1.03 in 2017 Q3. Its up 0.08, from 0.98 in 2017Q2. 64 funds opened positions while 129 raised stakes. S&T Bank & Trust Pa reported 2,373 shares. (NASDAQ:HOLX) for 34,345 shares. 2,267 were reported by Sun Life Finance Inc. (NYSE:ABBV). 4,640 were reported by Miller Inv Mgmt Lp. Tcw Group Inc stated it has 0.02% of its portfolio in AbbVie Inc. Renaissance Tech Lc holds 0.14% or 2.10 million shares in its portfolio. (NYSE:ABBV) earned "Hold" rating by BMO Capital Markets on Friday, April 28. (NASDAQ:EA) for 520,342 shares. Denmark-based C Gp A S has invested 0.18% in AbbVie Inc. (NASDAQ:HOLX). Marble Harbor Investment Counsel Limited Liability Company accumulated 10,000 shares. Millennium Mgmt Ltd Liability holds 0.2% or 1.09M shares. Barrett Asset Management Llc who had been investing in Pfizer Inc Com for a number of months, seems to be less bullish one the $218.55 billion market cap company. (NASDAQ:EA). Cohen Klingenstein Ltd has 0.21% invested in Electronic Arts Inc. (NASDAQ:EA) for 11,858 shares. Centers Of America holds 0.02% or 146 shares. (NASDAQ:EA) for 125 shares.

The Relative Volume of the company is 1.86 and Average Volume (3 months) is 5.32 million. It also reduced its holding in Cigna Corporation (NYSE:CI) by 659,431 shares in the quarter, leaving it with 3.08 million shares, and cut its stake in Abbvie Inc (NYSE:ABBV).

Since August 2, 2017, it had 0 insider purchases, and 25 sales for $27.37 million activity. $353,219 worth of stock was sold by Levy Lawrence M on Tuesday, October 10. Shares for $705,655 were sold by SALEKI-GERHARDT AZITA on Monday, September 11. (NASDAQ:EA) on Thursday, December 14. Gosebruch Henry O had sold 18,300 shares worth $1.66M on Monday, October 30. (NYSE:AGU) to report earnings on February, 8. Srouji Johny sold $1.70M worth of stock. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Therefore 20% are positive. Knowles Corporation had 21 analyst reports since August 20, 2015 according to SRatingsIntel. The stock has "Buy" rating by Jefferies on Monday, June 26. The firm has "Hold" rating given on Wednesday, June 29 by Benchmark. The firm earned "Buy" rating on Thursday, September 28 by Piper Jaffray. Citigroup upgraded AbbVie Inc. Finally, Barclays increased their price objective on AbbVie to $90.00 and gave the company an equal weight rating in a report on Friday, October 13th. The company was upgraded on Monday, October 26 by BTIG Research.

Among 13 analysts covering Knowles Corporation (NYSE:KN), 6 have Buy rating, 2 Sell and 5 Hold. Zacks Investment Research lowered AbbVie from a "buy" rating to a "hold" rating in a research note on Monday, January 22nd.

Orbis Investment Management, which manages about $160.64M US Long portfolio, decreased its stake in Centennial Resource Dev Inc by 170,001 shares to 664,150 shares, valued at $11.94M in 2017Q3, according to the filing.

Since August 3, 2017, it had 0 insider buys, and 6 sales for $39.31 million activity. BlackRock Inc. increased its holdings in shares of AbbVie by 2.0% in the second quarter. (NYSE:ABBV) was recently seen trading -8.03% away from the 50-day high and 24.61% separated from the 50-day low. Moreover, Johnson Fin Group has 0.36% invested in AbbVie Inc. RICHMOND TIMOTHY J. had sold 87,040 shares worth $8.57M on Monday, December 18. GONZALEZ RICHARD A sold 193,131 shares worth $13.71M.

Investors sentiment decreased to 0.85 in 2017 Q3. Its up 0.20, from 0.85 in 2017Q2. It dropped, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. (NASDAQ:HOLX). Fil Limited owns 113,184 shares. Employees Retirement Of Texas invested in 0.29% or 249,100 shares. (NASDAQ:EXPO). Blackrock Incorporated has invested 0.01% in Exponent, Inc. Edgewood Mngmt Limited Liability Company holds 79,630 shares. Convergence Ptnrs stated it has 1.34% in AbbVie Inc. Stevens First Principles Advsrs owns 0% invested in AbbVie Inc. (NYSE:ABBV). Capital Ww Investors holds 0.31% or 15.20M shares. Raymond James initiated the shares of ABBV in report on Friday, September 2 with "Outperform" rating. Norinchukin Fincl Bank The holds 20,876 shares. Bessemer Group Inc Inc reported 0% stake. (NYSE:ABBV). Interocean Cap Llc holds 10,417 shares or 0.14% of its portfolio. Nomura Incorporated owns 108,283 shares for 0.02% of their portfolio. Clifford Swan Inv Counsel owns 172,049 shares or 0.93% of their U.S. portfolio.